Investing Center Preview – Manage your investments and watch your net worth grow.
TOVX:NYSE American – Small Cap Stock (Biotechnology)
Theriva Biologics Inc – TOVX Stock Overview
Last Price | Today's Change | 52-Week Range | Trading Volume |
---|---|---|---|
1.19 | 0.07 (+6.24%) | 1.03 - 12.28 | 4.5 thousand (Above Avg) |
Market data as of 10:09AM 04/02/25. Quotes are delayed by at least 15 min.
Overview - TOVX
Open | 1.19 |
---|---|
Previous Close | 1.12 |
Day's Range | 1.15 - 1.19 |
Market Cap | 3.3M |
Avg Volume (10 Day) | 16.5K |
Price/Earnings (Trailing 12 Mo.) | -- |
Earnings Per Share (Trailing 12 Mo.) | -12.776 |
Dividend Yield | No Dividend |
One-Click Scorecard - TOVX


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
Performed well consistently? | Fail |
---|---|
Avoids excess debt? | Fail |
Converting sales to profits? | Fail |
Shareholder's money handled rationally? | Neutral |
Increased shareholder value? | Neutral |
Consistently increased owner earnings? | Fail |
Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
Pays a cash dividend? | Neutral |
---|---|
Room to increase dividends? | Fail |
Increased earnings over time? | Neutral |
Borrows within reasonable limits? | Pass |
Stock is undervalued? | Fail |
Have investors caught on? | Pass |
Has support of institutional investors? | Fail |
Has sufficient liquidity? | Pass |
Latest Headlines - TOVX
No news headlines available for TOVX
Industry Position - TOVX
TOVX | Industry Range | |
---|---|---|
Revenue Growth (1yr) | 0.00% | |
Net Income Growth (1yr) | -- | |
Total Debt/Equity | 0.08 | |
LT Debt/Equity | 0.05 | |
Earnings Yield | -- | |
Price/Sales | -- |
Competitors - TOVX
Company | Last | Change |
---|---|---|
Neon Bloom Inc | 0.01 | 0.00% |
Actavia Life Sciences Inc | 0.00 | 0.00% |
Artelo Biosciences Inc | 0.86 | 0.00% |
180 Life Sciences Corp | 1.02 | +7.23% |
Jaguar Health Inc | 4.52 | -5.04% |
Data is delayed by at least 15 min.